Finance

Lists
Why is 524711 up 6.17%?
Dive Deeper
524711:BOM
Vista Pharmaceuticals Ltd
₹6.37
+6.17%
(+0.37) 1D
Oct 12, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524711...
Open
₹6.29
High
₹6.49
Low
₹6.27
Mkt. cap
392.09M
Avg. vol.
12.12K
Volume
1.91K
52-wk high
₹10.50
52-wk low
₹5.32
EPS
-₹1.90
Shares outstanding
29.15M
No. of employees
30
Open
₹6.29
High
₹6.49
Low
₹6.27
Mkt. cap
392.09M
Avg. vol.
12.12K
Volume
1.91K
52-wk high
₹10.50
52-wk low
₹5.32
EPS
-₹1.90
Shares outstanding
29.15M
No. of employees
30
News stories
From web sources and news partners
About Vista Pharmaceuticals Ltd
CEO-
Employees30
Founded1991
Headquarters-
SectorPharmaceutical industry
Last report
Feb 13, 2026
Fiscal period
Q3 2026
- / -
Revenue / Est. (INR)
24.18M / -
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Jun 2026
Revenue
15.19M
14.62M
24.18M
-
Cost of goods sold
14.98M
14.63M
22.60M
-
Cost of revenue
14.98M
14.63M
22.60M
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.42M
5.68M
5.90M
5.12M
Operating expense
13.07M
36.36M
33.50M
10.31M
Total operating expenses
28.06M
50.99M
56.11M
10.31M
Operating income
-12.87M
-36.37M
-31.93M
-10.31M
Other non operating income
-1.10K
1.92M
897.00K
399.00K
EBT including unusual items
-14.80M
-36.22M
-32.80M
-13.27M
EBT excluding unusual items
-14.80M
-36.22M
-32.80M
-13.27M
Income tax expense
-1.90M
-10.34M
-9.61M
-3.41M
Effective tax rate
12.82%
28.53%
29.30%
25.71%
Other operating expenses
5.89M
28.69M
25.74M
3.31M
Net income
-12.90M
-25.88M
-23.19M
-9.86M
Net profit margin
-84.96%
-176.99%
-95.91%
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.93M
-1.78M
-1.77M
-3.36M
Net interest expenses
-1.93M
-1.78M
-1.77M
-3.36M
Depreciation and amortization charges
1.76M
1.99M
1.87M
1.88M
EBITDA
-11.02M
-34.49M
-30.08M
-8.43M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps